Pathfinders in Biopharma

RBC Capital Markets

Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.

About PodLP

PodLP is the leading podcast app for feature phones. With 10M+ installs in nearly every country, PodLP is available for KaiOS on the KaiStore and JioStore, as well as Cloud Phone and Android. If you're interested in promoting "Pathfinders in Biopharma" on PodLP, contact sales@podlp.com.

Screenshots are mockup renders of PodLP for KaiOS. Actual design may vary based on platform, operating system, and app version.

Pathfinders in Biopharma

Episodes (55)

Jan 27th No biotech bubble – but can the sector’s rally persist through 2026?
Sep 17, 2025 MindMed: Rethinking brain health with psychedelic therapy
Sep 3, 2025 Funding the future of retinal health with Eyepoint

Pathfinders in Biopharma

Jan 27, 2026
13¼ minutes
12 MB

Strong launches, positive sentiment, flowing capital, and favorable macro and policy indicators: the signals remain strong as the biotech sector enters 2026. Yet investors may need to search harder for opportunities this year, according to new RBC research. Brian Abrahams, Head of Global Healthcare Research, highlights some of the classes set for new breakthroughs, and points to the potential tripwires that lie ahead as biotech looks to continue its near-historic rally.

Pathfinders in Biopharma

No biotech bubble – but can the sector’s rally persist through 2026?

RBC Capital Markets

00:00 -13:14